Pacer Advisors
KURA icon

Pacer Advisors’s Kura Oncology KURA Stock Holding History

Pacer Advisors’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16K Buy
+1,428
New +$13.5K ﹤0.01% 2281
2024
Q3 		– Sell
-709
Closed -$14.6K – 2631
2024
Q2 		$14.6K Sell
709
-742
-51% -$15.3K ﹤0.01% 3489
2024
Q1 		$30.9K Buy
+1,451
New +$28.2K ﹤0.01% 3349
2021
Q2 		– Sell
-2,618
Closed -$74K – 1488
2021
Q1 		$74K Sell
2,618
-558
-18% -$17.7K ﹤0.01% 1351
2020
Q4 		$104K Buy
3,176
+1,804
+131% +$63.4K ﹤0.01% 1362
2020
Q3 		$42K Buy
+1,372
New +$30.3K ﹤0.01% 1309
2018
Q4 		– Sell
-2,518
Closed -$44K – 816
2018
Q3 		$44K Buy
+2,518
New +$48.3K ﹤0.01% 1149

Other funds holding KURA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $241M AUM 112.74% 1-Year Est. Return

Pacer Advisors's KURA Position: Q2 2026 in Review

Pacer Advisors opened a new position in Kura Oncology (KURA) in Q2 2026: 1,428 shares worth $16K. The stake represents ﹤0.01% of the portfolio and ranks #2281 among its holdings. This is a return to the name: Pacer Advisors previously reported a position in KURA as recently as Q2 2024.

Pacer Advisors first reported a position in KURA in Q3 2018 and has held it in 7 quarters since. The position peaked at $104K in Q4 2020. 221 funds tracked by Wall St. Rank hold KURA as of Q2 2026.

  • Pacer Advisors held 1,428 shares of Kura Oncology worth $16K as of Q2 2026.
  • Kura Oncology was a new Pacer Advisors position in Q2 2026.
  • Kura Oncology made up ﹤0.01% of Pacer Advisors's portfolio in Q2 2026, its #2281 holding.
  • Pacer Advisors first reported a position in Kura Oncology in Q3 2018 and has held it in 7 quarters since.
  • Pacer Advisors's Kura Oncology position peaked at $104K in Q4 2020.
  • 221 funds tracked by Wall St. Rank held Kura Oncology as of Q2 2026.

Based on Pacer Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.